Search

Maria Marvich

Examiner (ID: 9363)

Most Active Art Unit
1633
Art Unit(s)
1633, 1634, 1631, 1636
Total Applications
1459
Issued Applications
618
Pending Applications
253
Abandoned Applications
627

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 5373658 [patent_doc_number] => 20090311219 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-17 [patent_title] => 'Oncolytic Adenoviruses for Cancer Treatment' [patent_app_type] => utility [patent_app_number] => 12/184881 [patent_app_country] => US [patent_app_date] => 2008-08-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 12814 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0311/20090311219.pdf [firstpage_image] =>[orig_patent_app_number] => 12184881 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/184881
Oncolytic Adenoviruses for Cancer Treatment Jul 31, 2008 Abandoned
Array ( [id] => 6234847 [patent_doc_number] => 20100266551 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-21 [patent_title] => 'ADENO-ASSOCIATED VIRAL VECTORS FOR THE EXPRESSION OF DYSFERLIN' [patent_app_type] => utility [patent_app_number] => 12/670451 [patent_app_country] => US [patent_app_date] => 2008-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6220 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0266/20100266551.pdf [firstpage_image] =>[orig_patent_app_number] => 12670451 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/670451
ADENO-ASSOCIATED VIRAL VECTORS FOR THE EXPRESSION OF DYSFERLIN Jul 24, 2008 Abandoned
Array ( [id] => 5558908 [patent_doc_number] => 20090270485 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-29 [patent_title] => 'Cell specific replication-competent viral vectors comprising a self processing peptide cleavage site' [patent_app_type] => utility [patent_app_number] => 12/220686 [patent_app_country] => US [patent_app_date] => 2008-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 22241 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0270/20090270485.pdf [firstpage_image] =>[orig_patent_app_number] => 12220686 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/220686
Cell specific replication-competent viral vectors comprising a self processing peptide cleavage site Jul 23, 2008 Abandoned
Array ( [id] => 6328362 [patent_doc_number] => 20100197767 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-05 [patent_title] => 'NUCLEIC ACID CONSTRUCT SYSTEMS CAPABLE OF DAIGNOSING OR TREATING A CELL STATE' [patent_app_type] => utility [patent_app_number] => 12/452573 [patent_app_country] => US [patent_app_date] => 2008-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 15003 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0197/20100197767.pdf [firstpage_image] =>[orig_patent_app_number] => 12452573 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/452573
NUCLEIC ACID CONSTRUCT SYSTEMS CAPABLE OF DAIGNOSING OR TREATING A CELL STATE Jul 9, 2008 Abandoned
Array ( [id] => 6575264 [patent_doc_number] => 20100129399 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-27 [patent_title] => 'LINEAR EXPRESSION CONSTRUCTS FOR PRODUCTION OF INFLUENZA VIRUS PARTICLES' [patent_app_type] => utility [patent_app_number] => 12/666459 [patent_app_country] => US [patent_app_date] => 2008-06-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6441 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0129/20100129399.pdf [firstpage_image] =>[orig_patent_app_number] => 12666459 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/666459
LINEAR EXPRESSION CONSTRUCTS FOR PRODUCTION OF INFLUENZA VIRUS PARTICLES Jun 25, 2008 Abandoned
Array ( [id] => 5271594 [patent_doc_number] => 20090075370 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-19 [patent_title] => 'Vectors' [patent_app_type] => utility [patent_app_number] => 12/139035 [patent_app_country] => US [patent_app_date] => 2008-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 15456 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0075/20090075370.pdf [firstpage_image] =>[orig_patent_app_number] => 12139035 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/139035
Vectors Jun 12, 2008 Abandoned
Array ( [id] => 5349303 [patent_doc_number] => 20090004664 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-01 [patent_title] => 'HCV NS3 replicon shuttle vectors' [patent_app_type] => utility [patent_app_number] => 12/156871 [patent_app_country] => US [patent_app_date] => 2008-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 6318 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20090004664.pdf [firstpage_image] =>[orig_patent_app_number] => 12156871 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/156871
HCV NS3 replicon shuttle vectors Jun 4, 2008 Abandoned
Array ( [id] => 4759951 [patent_doc_number] => 20080312177 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-18 [patent_title] => 'SERCA2 THERAPEUTIC COMPOSITIONS AND METHODS OF USE' [patent_app_type] => utility [patent_app_number] => 12/132533 [patent_app_country] => US [patent_app_date] => 2008-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 23737 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0312/20080312177.pdf [firstpage_image] =>[orig_patent_app_number] => 12132533 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/132533
SERCA2 THERAPEUTIC COMPOSITIONS AND METHODS OF USE Jun 2, 2008 Abandoned
Array ( [id] => 5416410 [patent_doc_number] => 20090042297 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-12 [patent_title] => 'Piggybac transposon-based vectors and methods of nucleic acid integration' [patent_app_type] => utility [patent_app_number] => 12/156531 [patent_app_country] => US [patent_app_date] => 2008-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 35698 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0042/20090042297.pdf [firstpage_image] =>[orig_patent_app_number] => 12156531 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/156531
Piggybac transposon-based vectors and methods of nucleic acid integration Jun 1, 2008 Abandoned
Array ( [id] => 4758869 [patent_doc_number] => 20080311095 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-18 [patent_title] => 'Methods and compositions for increased transgene expression' [patent_app_type] => utility [patent_app_number] => 12/154439 [patent_app_country] => US [patent_app_date] => 2008-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 14959 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0311/20080311095.pdf [firstpage_image] =>[orig_patent_app_number] => 12154439 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/154439
Methods and compositions for increased transgene expression May 21, 2008 Abandoned
Array ( [id] => 5569385 [patent_doc_number] => 20090252763 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-08 [patent_title] => 'BIOLOGICAL ADJUVANTS' [patent_app_type] => utility [patent_app_number] => 12/121119 [patent_app_country] => US [patent_app_date] => 2008-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 1526 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0252/20090252763.pdf [firstpage_image] =>[orig_patent_app_number] => 12121119 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/121119
BIOLOGICAL ADJUVANTS May 14, 2008 Abandoned
Array ( [id] => 5446009 [patent_doc_number] => 20090047235 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-19 [patent_title] => 'Paratransgenesis to Control Termites or Other Social Insects' [patent_app_type] => utility [patent_app_number] => 12/120717 [patent_app_country] => US [patent_app_date] => 2008-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7268 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0047/20090047235.pdf [firstpage_image] =>[orig_patent_app_number] => 12120717 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/120717
Paratransgenesis to Control Termites or Other Social Insects May 14, 2008 Abandoned
Array ( [id] => 6262323 [patent_doc_number] => 20100297085 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-25 [patent_title] => 'Synthetic Herpes Simplex Viruses Type-1 for Treatment of Cancers' [patent_app_type] => utility [patent_app_number] => 12/598937 [patent_app_country] => US [patent_app_date] => 2008-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 16775 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0297/20100297085.pdf [firstpage_image] =>[orig_patent_app_number] => 12598937 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/598937
Synthetic herpes simplex viruses type-1 for treatment of cancers May 8, 2008 Issued
Array ( [id] => 9047012 [patent_doc_number] => 08541566 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-09-24 [patent_title] => 'Promoter inducible by reactive oxygen species and vector comprising the same' [patent_app_type] => utility [patent_app_number] => 12/597891 [patent_app_country] => US [patent_app_date] => 2008-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 23 [patent_no_of_words] => 9075 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12597891 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/597891
Promoter inducible by reactive oxygen species and vector comprising the same Apr 24, 2008 Issued
Array ( [id] => 6149330 [patent_doc_number] => 20110020925 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-27 [patent_title] => 'NEW MODULATING MOLECULES FOR AN IMPROVED REGULATED EXPRESSION SYSTEM' [patent_app_type] => utility [patent_app_number] => 12/594941 [patent_app_country] => US [patent_app_date] => 2008-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 73 [patent_figures_cnt] => 73 [patent_no_of_words] => 70898 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0020/20110020925.pdf [firstpage_image] =>[orig_patent_app_number] => 12594941 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/594941
NEW MODULATING MOLECULES FOR AN IMPROVED REGULATED EXPRESSION SYSTEM Apr 10, 2008 Abandoned
Array ( [id] => 4682253 [patent_doc_number] => 20080248479 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-09 [patent_title] => 'Methods for Isolating and Characterizing Endogenous mRNA-Protein (mRNP) Complexes' [patent_app_type] => utility [patent_app_number] => 12/049862 [patent_app_country] => US [patent_app_date] => 2008-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 13923 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0248/20080248479.pdf [firstpage_image] =>[orig_patent_app_number] => 12049862 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/049862
Methods for isolating and characterizing endogenous mRNA-protein (mRNP) complexes Mar 16, 2008 Issued
Array ( [id] => 4663621 [patent_doc_number] => 20080254528 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-16 [patent_title] => 'Baculovirus Expression System' [patent_app_type] => utility [patent_app_number] => 12/047469 [patent_app_country] => US [patent_app_date] => 2008-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 13211 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0254/20080254528.pdf [firstpage_image] =>[orig_patent_app_number] => 12047469 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/047469
Baculovirus expression system Mar 12, 2008 Issued
Array ( [id] => 5360553 [patent_doc_number] => 20090035347 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-05 [patent_title] => 'ISOLATED STROMAL CELLS AND METHODS OF USING THE SAME' [patent_app_type] => utility [patent_app_number] => 12/043903 [patent_app_country] => US [patent_app_date] => 2008-03-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 16024 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 23 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0035/20090035347.pdf [firstpage_image] =>[orig_patent_app_number] => 12043903 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/043903
ISOLATED STROMAL CELLS AND METHODS OF USING THE SAME Mar 5, 2008 Abandoned
Array ( [id] => 10090268 [patent_doc_number] => 09127082 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-09-08 [patent_title] => 'MANF2 for treatment of Parkinson\'s disease' [patent_app_type] => utility [patent_app_number] => 12/037535 [patent_app_country] => US [patent_app_date] => 2008-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 25997 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 77 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12037535 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/037535
MANF2 for treatment of Parkinson's disease Feb 25, 2008 Issued
Array ( [id] => 6530206 [patent_doc_number] => 20100221225 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-02 [patent_title] => 'COMPOSITIONS AND METHODS FOR TREATING GLYCOGEN STORAGE DISEASES' [patent_app_type] => utility [patent_app_number] => 12/305869 [patent_app_country] => US [patent_app_date] => 2008-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 20511 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0221/20100221225.pdf [firstpage_image] =>[orig_patent_app_number] => 12305869 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/305869
COMPOSITIONS AND METHODS FOR TREATING GLYCOGEN STORAGE DISEASES Feb 24, 2008 Abandoned
Menu